Q1 2026 Holdings
Filed 2026-05-15 | 50 holdings | $159.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $32.5M | 100,781 | 20.3% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $14.8M | 2,834,652 | 9.3% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $12.8M | 512,160 | 8.0% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $10.3M | 446,255 | 6.4% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $10.0M | 492,893 | 6.3% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $9.3M | 583,333 | 5.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $8.6M | 77,000 | 5.4% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $7.0M | 8,753,290 | 4.4% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $6.7M | 740,000 | 4.2% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $4.7M | 1,720,000 | 3.0% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $4.3M | 827,500 | 2.7% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $3.9M | 700,000 | 2.4% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $3.4M | 2,099,652 | 2.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $3.0M | 250,000 | 1.9% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.8M | 185,122 | 1.7% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $2.5M | 352,000 | 1.6% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $2.5M | 540,000 | 1.6% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $2.5M | 471,559 | 1.6% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $2.3M | 2,668,395 | 1.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.3M | 750,000 | 1.4% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $2.0M | 102,000 | 1.3% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $1.9M | 285,710 | 1.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.8M | 91,123 | 1.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $1.1M | 294,643 | 0.7% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $1.0M | 135,315 | 0.6% |
| Nasus Pharma LTD | ORD SHS | M7071P109 | $797.8K | 359,390 | 0.5% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $560.0K | 84,849 | 0.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $407.6K | 6,500 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $390.0K | 3,700 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $355.2K | 160,000 | 0.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $298.0K | 11,000 | 0.2% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $262.0K | 100,000 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $248.0K | 16,000 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $244.1K | 26,000 | 0.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $233.6K | 10,000 | 0.1% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $220.0K | 40,000 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $218.7K | 10,000 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $212.8K | 20,000 | 0.1% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $161.0K | 25,000 | 0.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $156.0K | 80,000 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $153.0K | 20,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $148.5K | 33,000 | 0.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $120.1K | 14,285 | 0.1% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $103.9K | 18,000 | 0.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $90.5K | 73,000 | 0.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $86.7K | 30,000 | 0.1% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $83.6K | 15,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $72.9K | 45,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $23.0K | 70,000 | 0.0% |